FinanceAragen Life Sciences Eyes IPO as It Expands Global Footprint with Biologics and ADCs By Reetam Bodhak Goldman Sachs-backed Aragen Life Sciences is making waves in the pharmaceutical industry with aggressive expansion plans and fresh investments positioning...